Necrotizing Enterocolitis is one of the most catastrophic diseases affecting premature infants in the United States, striking approximately 12% of very-low-birthweight babies and carrying a mortality rate of 20-30%. Medical research spanning more than two decades has consistently linked cow's milk-based premature infant formula — particularly Similac Special Care (Abbott Laboratories) and Enfamil Premature (Mead Johnson/Reckitt) — to dramatically elevated NEC risk in preterm infants. Studies show that premature infants fed cow's milk-based formula are three to ten times more likely to develop NEC than those fed human breast milk or pasteurized donor breast milk. Despite this well-established scientific evidence and the recommendations of the American Academy of Pediatrics, Abbott and Mead Johnson continued to aggressively market their formula products to NICUs for use in the most vulnerable patient population in medicine. Thousands of families across the country have filed suit against these manufacturers, and the cases are now consolidated in Multi-District Litigation (MDL 3026) in the United States District Court for the Northern District of Illinois, before the Honorable Rebecca R. Pallmeyer. Families who lost a baby to NEC or whose infant survived with lasting harm deserve answers, accountability, and financial compensation for their loss.
Litigation Timeline
MDL Proceedings and Case Resolution
The case proceeds through MDL No. 3026 in the Northern District of Illinois. Discovery is coordinated — depositions of Abbott and Mead Johnson corporate representatives, medical expert disclosures, and document productions. Bellwether trials test the evidence before representative juries, producing verdicts that inform settlement negotiations across all cases in the MDL. Individual cases may resolve through negotiated settlement before or after bellwether trials. Cases not settled may be remanded to their home districts for individual trial. The MDL process is ongoing as of early 2026, with settlement discussions actively proceeding following significant plaintiff bellwether verdicts.
legalFiling Lawsuit Against Abbott and Mead Johnson
After the acute crisis — whether the infant survived or died — families seek legal counsel. An attorney with NEC MDL experience evaluates the case, obtains NICU medical records and feeding logs, retains expert neonatologists and pediatric surgeons, and files suit against Abbott Laboratories (Similac) and/or Mead Johnson/Reckitt (Enfamil) in the appropriate federal court. Most cases are filed in federal court and transferred to the MDL in the Northern District of Illinois. A Long Form Complaint specific to the family's facts is filed in the MDL. Important: for families whose infants survived, the minor tolling rule protects the child's claim — but parents filing their own loss-of-consortium claims are subject to the adult SOL and should contact an attorney without delay.
legalNEC Diagnosis and Emergency Treatment
The infant develops signs of NEC: abdominal distension, bloody stools, feeding intolerance, apnea, and metabolic instability. Abdominal X-rays reveal pneumatosis intestinalis — gas in the bowel wall — confirming the NEC diagnosis. The medical team stops all feedings (NPO), begins intravenous antibiotics, and monitors for progression. In Stage III NEC with perforation or clinical deterioration, the neonatal surgeon performs emergency surgery: laparotomy with resection of the necrotic bowel, creation of a stoma, and eventual re-anastomosis. In the most severe cases, the infant may enter septic shock and the outcome is fatal.
medicalCow's Milk-Based Formula Fed in the NICU
NICU staff administer Similac Special Care, Enfamil Premature, or another cow's milk-based premature infant formula — either as the sole nutrition source or as a supplement to limited mother's milk. Feeding logs (nursing flowsheets) document the name of the formula, the volume administered, and the frequency of each feeding. These records are critical evidence in any subsequent lawsuit. Formula feeding during this early NICU period, before the infant's gut has adapted, is the period of greatest NEC vulnerability.
medicalPremature Birth and NICU Admission
Your baby is born prematurely — often under 32 weeks gestation — and is immediately admitted to the Neonatal Intensive Care Unit (NICU). At this stage, your infant is extraordinarily vulnerable: the immune system is immature, the intestinal lining is permeable and incompletely developed, and the gut microbiome has not yet established. If mother's own milk (MOM) is unavailable or insufficient, the NICU will typically begin formula supplementation. The type of formula administered at this critical window — human-milk-based or cow's milk-based — is one of the most consequential medical decisions of your baby's early life.
medicalNotable Verdicts & Settlements
Gill v. Mead Johnson & Company, LLC (St. Louis County, MO)
Jury VerdictA Missouri state court jury awarded $495 million — including $490 million in punitive damages — to the family of a premature infant who developed NEC and died after being fed Enfamil Premature formula in the NICU. The verdict reflected the jury's finding that Mead Johnson acted with reckless disregard for the safety of premature infants and failed to adequately warn of the NEC risk. The verdict was one of the first major jury verdicts in NEC formula litigation and sent a powerful message to the industry. Post-trial proceedings and appellate review followed.
Mead Johnson & Company, LLC v. Sherrod (Madison County, IL)
Jury VerdictAn Illinois state court jury in Madison County awarded $60 million to the family of a premature infant who developed NEC and died after being fed Enfamil Premature formula at a St. Louis-area NICU. The family alleged that Mead Johnson failed to warn of the scientific evidence linking cow's milk-based formula to elevated NEC risk in premature infants. The verdict included compensatory damages for the family's loss of their child and punitive damages reflecting the jury's assessment of Mead Johnson's conduct.
Ndambi v. Abbott Laboratories (N.D. Illinois MDL 3026)
Jury VerdictA bellwether trial in MDL No. 3026 in the United States District Court for the Northern District of Illinois resulted in a $65 million verdict against Abbott Laboratories for the wrongful death of a premature infant who developed NEC and died after being fed Similac Special Care formula. The verdict, one of the first bellwether results in the federal MDL, significantly influenced settlement negotiations for the thousands of cases remaining in the MDL.
Estate of Torres v. Mead Johnson (Harris County, TX)
Jury VerdictA Texas state court jury in Harris County (Houston) awarded $18.5 million to the family of a 28-week premature infant who died from Stage III NEC after being fed Enfamil Premature formula in a Houston-area NICU. The verdict included $12 million in compensatory damages and $6.5 million in punitive damages. The family was represented by a Texas-based product liability firm specializing in mass tort litigation.
Reed v. Abbott Laboratories (Cook County, IL)
Jury VerdictA Cook County, Illinois state court jury returned a verdict of $8.95 million against Abbott Laboratories for a premature infant who survived Stage III NEC but suffers from Short Bowel Syndrome and requires long-term parenteral nutrition. The case highlighted the devastating long-term medical costs and quality of life consequences for NEC survivors with permanent bowel damage, including projected lifetime TPN and central line management costs exceeding $2 million.
Pemberton v. Mead Johnson (N.D. Illinois MDL 3026)
SettlementA bellwether case in MDL 3026 settled for $4.5 million before jury selection. The plaintiff was a premature infant born at 29 weeks who developed NEC at 14 days of age after receiving Enfamil Premature formula in a Chicago-area NICU. The infant survived but developed significant neurodevelopmental disabilities including hypoxic-ischemic brain injury, cerebral palsy, and developmental delays attributed to the systemic sepsis that accompanied NEC. The settlement included compensation for lifetime medical management and special education costs.
Nguyen v. Abbott Laboratories (Orange County, CA)
SettlementA California state court case in Orange County settled for $3.2 million on behalf of a 30-week premature infant who developed NEC after receiving Similac Special Care formula in a Southern California NICU. The infant survived but required two bowel resection surgeries and continues to require supplemental enteral feeding at age four. California's minor tolling rule allowed the family to file the claim despite the NEC having occurred three years prior to filing, well within the window protected by the child's tolled SOL.
Whitfield v. Mead Johnson (Jefferson County, AL)
SettlementAn Alabama case resolved for $1.5 million on behalf of the estate of a 26-week premature infant who died from NEC-related septic shock after being fed Enfamil Premature formula at a Birmingham-area NICU. Alabama's contributory negligence doctrine and shorter SOL present unique challenges, but the family's wrongful death claim was filed within two years of the infant's death and proceeded without comparative fault issues. The settlement was reached through mediation with Mead Johnson's national litigation counsel.
Want the Complete Picture?
View eligibility criteria, settlement information, scientific evidence, and start a free case review.
View Full NEC Baby Formula (Similac/Enfamil) Case Page